{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:01:15Z","timestamp":1790787675768,"version":"4.1.0"},"reference-count":73,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Neurol"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Most patients with epilepsy will benefit from seizure control with one of an array of chronic antiseizure medications. Knowledge of the potential long-term effects of these medications is critical to prevent adverse consequences on overall health. Antiseizure medications vary in their capacities to affect the brain and peripheral nerves, hormones, bone mineralization, cardiovascular risk, renal health, hepatic, hematological, and dermatological systems. Understanding of pathophysiology and population risk has evolved, although most of the data available are still on older generation antiseizure medications such as phenytoin, carbamazepine, and valproic acid. The enzyme-inducing properties of some antiseizure medications make their effects on cardiovascular risk and bone health detrimental. Few clear guidelines exist for monitoring long-term effects of medication therapy for epilepsy. When selecting an antiseizure medication, consideration should be given to the individual patient's risks of adverse consequences on other organ systems. During monitoring of patients on chronic therapy, screening tools such as metabolic panels and bone density measurements can help stratify risk and guide management.<\/jats:p>","DOI":"10.1055\/a-1958-0802","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T23:55:40Z","timestamp":1665446140000},"page":"583-593","source":"Crossref","is-referenced-by-count":15,"title":["Long-Term Effects of Antiseizure Medications"],"prefix":"10.1055","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2352-9025","authenticated-orcid":false,"given":"Carla","family":"LoPinto-Khoury","sequence":"additional","affiliation":[{"name":"Department of Neurology, Lewis Katz Temple School of Medicine, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"issue":"23","key":"ref1","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1212\/WNL.0000000000012944","article-title":"Antiseizure medication withdrawal in seizure-free patients: practice advisory update summary: report of the AAN Guideline Subcommittee","volume":"97","author":"D Gloss","year":"2021","journal-title":"Neurology"},{"issue":"05","key":"ref2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S1059-1311(02)00267-4","article-title":"Cerebellar volume and long-term use of phenytoin","volume":"12","author":"F A De Marcos","year":"2003","journal-title":"Seizure"},{"issue":"03","key":"ref3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.seizure.2012.12.004","article-title":"The role of CYP2C9 polymorphisms in phenytoin-related cerebellar atrophy","volume":"22","author":"C A Twardowschy","year":"2013","journal-title":"Seizure"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.seizure.2018.01.019","article-title":"Phenytoin-related ataxia in patients with epilepsy: clinical and radiological characteristics","volume":"56","author":"P D Shanmugarajah","year":"2018","journal-title":"Seizure"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.14581\/jer.20016","article-title":"Irreversible cerebellar atrophy as a complication of short-term phenytoin exposure: clinical improvement following discontinuation of the culprit","volume":"10","author":"H Algahtani","year":"2020","journal-title":"J Epilepsy Res"},{"issue":"07","key":"ref6","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/jnnp.45.7.620","article-title":"Anticonvulsant peripheral neuropathy: a clinical and electrophysiological study of patients on single drug treatment with phenytoin, carbamazepine or barbiturates","volume":"45","author":"S D Shorvon","year":"1982","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0404.2009.01275.x","article-title":"Effects of the antiepileptic drugs on peripheral nerve function","volume":"121","author":"E Boylu","year":"2010","journal-title":"Acta Neurol Scand"},{"issue":"08","key":"ref8","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.seizure.2014.05.004","article-title":"New antiepileptic drugs and women","volume":"23","author":"A Reimers","year":"2014","journal-title":"Seizure"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.eplepsyres.2005.08.004","article-title":"Serum thyroid hormone balance and lipid profile in patients with epilepsy","volume":"66","author":"S A Hamed","year":"2005","journal-title":"Epilepsy Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"107555","DOI":"10.1016\/j.yebeh.2020.107555","article-title":"The effect of levetiracetam and oxcarbazepine monotherapy on thyroid hormones and bone metabolism in children with epilepsy: a prospective study","volume":"113","author":"K L Shi","year":"2020","journal-title":"Epilepsy Behav"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.seizure.2016.01.010","article-title":"Effects of antiepileptic drug on thyroid hormones in patients with epilepsy: a meta-analysis","volume":"35","author":"Y X Zhang","year":"2016","journal-title":"Seizure"},{"issue":"04","key":"ref12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11940-010-0080-y","article-title":"Antiepileptic drugs and markers of vascular risk","volume":"12","author":"C Lopinto-Khoury","year":"2010","journal-title":"Curr Treat Options Neurol"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jamaneurol.2021.3424","article-title":"Association of enzyme-inducing antiseizure drug use with long-term cardiovascular disease","volume":"78","author":"C B Josephson","year":"2021","journal-title":"JAMA Neurol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.yebeh.2018.05.021","article-title":"Adults with an epilepsy history, notably those 45-64 years old or at the lowest income levels, more often report heart disease than adults without an epilepsy history","volume":"86","author":"M Zack","year":"2018","journal-title":"Epilepsy Behav"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"106946","DOI":"10.1016\/j.yebeh.2020.106946","article-title":"The epileptic heart: concept and clinical evidence","volume":"105","author":"R L Verrier","year":"2020","journal-title":"Epilepsy Behav"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.eplepsyres.2007.07.005","article-title":"Cardiovascular risk factors and homocysteine in epilepsy","volume":"76","author":"J O Elliott","year":"2007","journal-title":"Epilepsy Res"},{"issue":"02","key":"ref17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/epi.16420","article-title":"Hyperlipidemia in patients newly treated with anticonvulsants: a population study","volume":"61","author":"S Mintzer","year":"2020","journal-title":"Epilepsia"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.eplepsyres.2015.03.002","article-title":"Antiepileptic drug use for treatment of epilepsy and dyslipidemia: systematic review","volume":"113","author":"M V Vyas","year":"2015","journal-title":"Epilepsy Res"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"H704","DOI":"10.1152\/ajpheart.00580.2001","article-title":"Carbamazepine increases atherogenic lipoproteins: mechanism of action in male adults","volume":"282","author":"S Br\u00e4mswig","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1111\/epi.16745","article-title":"Effects of lacosamide and carbamazepine on lipids in a randomized trial","volume":"61","author":"S Mintzer","year":"2020","journal-title":"Epilepsia"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/epi.14554","article-title":"Impact of carbamazepine, lamotrigine, and levetiracetam on vascular risk markers and lipid-lowering agents in the elderly","volume":"59","author":"S Mintzer","year":"2018","journal-title":"Epilepsia"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.21307\/jepil-2018-005","article-title":"The potential mechanisms of effect of valproic acid on lipid profiles: an updated review","volume":"26","author":"S Jaeri","year":"2018","journal-title":"J Epileptol"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/epi4.12349","article-title":"Comparative effectiveness of antiepileptic drugs in juvenile myoclonic epilepsy","volume":"4","author":"K Silvennoinen","year":"2019","journal-title":"Epilepsia Open"},{"issue":"05","key":"ref24","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.12669\/pjms.335.12982","article-title":"Correlation between hyperhomocysteinemia and common carotid artery intima media thickness in carbamazepine treated epileptic patients using ultrasonography","volume":"33","author":"S Bano","year":"2017","journal-title":"Pak J Med Sci"},{"issue":"04","key":"ref25","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/0883073814551388","article-title":"Atherosclerotic effects of long-term old and new antiepileptic drugs monotherapy: a cross-sectional comparative study","volume":"30","author":"R M El-Farahaty","year":"2015","journal-title":"J Child Neurol"},{"issue":"02","key":"ref26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3181\/00379727-180-42189","article-title":"Effect of anticonvulsant drugs on plasma total cholesterol, high-density lipoprotein cholesterol, and apolipoproteins A and B in children with epilepsy","volume":"180","author":"M N Reddy","year":"1985","journal-title":"Proc Soc Exp Biol Med"},{"issue":"06","key":"ref27","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.eplepsyres.2014.04.006","article-title":"Vascular function and risk factors in children with epilepsy: associations with sodium valproate and carbamazepine","volume":"108","author":"N Keenan","year":"2014","journal-title":"Epilepsy Res"},{"issue":"08","key":"ref28","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.seizure.2006.08.006","article-title":"Capillary microscopy and hemorheology in children during antiepileptic monotherapy with carbamazepine and valproate","volume":"15","author":"T Gerstner","year":"2006","journal-title":"Seizure"},{"issue":"04","key":"ref29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3988\/jcn.2017.13.4.371","article-title":"Effects of antiepileptic drugs on the carotid artery intima-media thickness in epileptic patients","volume":"13","author":"Q Lai","year":"2017","journal-title":"J Clin Neurol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"108432","DOI":"10.1016\/j.yebeh.2021.108432","article-title":"Carotid intima-media and epicardial adipose tissue thickness in adult patients with epilepsy taking anti-seizure medication and its long-term significance","volume":"125","author":"B Safarpour Lima","year":"2021","journal-title":"Epilepsy Behav"},{"issue":"05","key":"ref31","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7326\/M14-1333","article-title":"Screening for asymptomatic carotid artery stenosis: U.S. Preventive Services Task Force recommendation statement","volume":"161","author":"M L LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"issue":"03","key":"ref32","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jamaneurol.2013.5993","article-title":"Vitamin D as an early predictor of multiple sclerosis activity and progression","volume":"71","author":"A Ascherio","year":"2014","journal-title":"JAMA Neurol"},{"issue":"03","key":"ref33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/imm.12610","article-title":"Vitamin D immunoregulation through dendritic cells","volume":"148","author":"M Bscheider","year":"2016","journal-title":"Immunology"},{"issue":"01","key":"ref34","doi-asserted-by":"publisher","DOI":"10.15406\/mojap.2018.05.00157","article-title":"Non calcaemic and non-osteogenic functions of vitamin D: a brief review","volume":"5","author":"S Behera","year":"2018","journal-title":"MOJ Anat Physiol"},{"issue":"06","key":"ref35","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jcot.2019.07.004","article-title":"Vitamin D for skeletal and non-skeletal health: what we should know","volume":"10","author":"N Charoenngam","year":"2019","journal-title":"J Clin Orthop Trauma"},{"issue":"18","key":"ref36","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1056\/NEJM197211022871803","article-title":"Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults","volume":"287","author":"T J Hahn","year":"1972","journal-title":"N Engl J Med"},{"issue":"08","key":"ref37","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.eplepsyres.2014.06.008","article-title":"Low vitamin D levels are common in patients with epilepsy","volume":"108","author":"D L Teagarden","year":"2014","journal-title":"Epilepsy Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.15761\/JTS.1000378","article-title":"Common drugs as vitamin D disruptors","volume":"6","author":"U Gr\u00f6ber","year":"2020","journal-title":"J Transl Sci"},{"issue":"06","key":"ref39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02939839","article-title":"Factors associated with the biochemical changes in vitamin D and calcium metabolism in institutionalized patients with epilepsy","volume":"155","author":"H Gough","year":"1986","journal-title":"Ir J Med Sci"},{"issue":"03","key":"ref40","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1528-1167.2006.00460.x","article-title":"Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine","volume":"47","author":"S Mintzer","year":"2006","journal-title":"Epilepsia"},{"issue":"04","key":"ref41","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1515\/jpem-2006-190411","article-title":"Effect of carbamazepine and valproic acid on bone mineral density, IGF-I and IGFBP-3","volume":"19","author":"S Kumandas","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"02","key":"ref42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-0404.1984.tb00806.x","article-title":"Carbamazepine and bone mineral metabolism","volume":"70","author":"V Hoikka","year":"1984","journal-title":"Acta Neurol Scand"},{"issue":"01","key":"ref43","first-page":"16","article-title":"An examination of the mutual effects of valproic acid, carbamazepine, and phenobarbital on 25-hydroxyvitamin D levels and thyroid function tests","volume":"45","author":"M I Turan","year":"2014","journal-title":"Neuropediatrics"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"106829","DOI":"10.1016\/j.eplepsyres.2021.106829","article-title":"Impact of carbamazepine on vitamin D levels: a meta-analysis","volume":"178","author":"C LoPinto-Khoury","year":"2021","journal-title":"Epilepsy Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.seizure.2017.03.013","article-title":"The effect of VPA on bone: From clinical studies to cell cultures - the molecular mechanisms revisited","volume":"48","author":"D A Pitetzis","year":"2017","journal-title":"Seizure"},{"issue":"01","key":"ref46","first-page":"e13","article-title":"Vitamin D status in epileptic children on valproic acid; a case-control study","volume":"8","author":"A T Abdullah","year":"2020","journal-title":"Arch Acad Emerg Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.seizure.2019.10.017","article-title":"Effects of valproic acid on bone mineral density and bone metabolism: a meta-analysis","volume":"73","author":"D Fan","year":"2019","journal-title":"Seizure"},{"issue":"12","key":"ref48","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/0306-9877(79)90105-1","article-title":"Phenytoin, hemorrhage, skeletal defects and vitamin K in the newborn","volume":"5","author":"D A Keith","year":"1979","journal-title":"Med Hypotheses"},{"issue":"05","key":"ref49","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1528-1167.2009.02130.x","article-title":"Management issues for women with epilepsy\u2013focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"50","author":"C L Harden","year":"2009","journal-title":"Epilepsia"},{"issue":"S 02","key":"ref50","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.yebeh.2003.11.029","article-title":"Epilepsy and bone health in adults","volume":"5","author":"A M Pack","year":"2004","journal-title":"Epilepsy Behav"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.seizure.2021.01.008","article-title":"Metabolic bone disease in patients with epilepsy and the use of antiepileptic drugs - insight from a Danish cross-sectional study","volume":"86","author":"D R Baddoo","year":"2021","journal-title":"Seizure"},{"issue":"05","key":"ref52","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2220\/biomedres.38.297","article-title":"Effects of the antiepileptic drugs topiramate and lamotrigine on bone metabolism in rats","volume":"38","author":"J Kanda","year":"2017","journal-title":"Biomed Res"},{"issue":"10","key":"ref53","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/j.1528-1167.2011.03131.x","article-title":"The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy","volume":"52","author":"K Heo","year":"2011","journal-title":"Epilepsia"},{"issue":"10","key":"ref54","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1111\/epi.16678","article-title":"Effects of zonisamide monotherapy on bone health in drug-naive epileptic patients","volume":"61","author":"D L Koo","year":"2020","journal-title":"Epilepsia"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"107489","DOI":"10.1016\/j.yebeh.2020.107489","article-title":"Effects of valproate, lamotrigine, and levetiracetam monotherapy on bone health in newly diagnosed adult patients with epilepsy","volume":"113","author":"Y Guo","year":"2020","journal-title":"Epilepsy Behav"},{"issue":"06","key":"ref56","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1111\/epi.12162","article-title":"Effect of switching hepatic enzyme-inducer antiepileptic drug to levetiracetam on bone mineral density, 25 hydroxyvitamin D, and parathyroid hormone in young adult patients with epilepsy","volume":"54","author":"K Phabphal","year":"2013","journal-title":"Epilepsia"},{"issue":"02","key":"ref58","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/epi4.12392","article-title":"Are we responding effectively to bone mineral density loss and fracture risks in people with epilepsy?","volume":"5","author":"A S Miller","year":"2020","journal-title":"Epilepsia Open"},{"issue":"12","key":"ref59","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/epi.13593","article-title":"Antiepileptic drugs and hyponatremia in older adults: two population-based cohort studies","volume":"57","author":"S Gandhi","year":"2016","journal-title":"Epilepsia"},{"issue":"03","key":"ref60","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.seizure.2013.11.015","article-title":"Frequency of and risk factors for oxcarbazepine-induced severe and symptomatic hyponatremia","volume":"23","author":"Y S Kim","year":"2014","journal-title":"Seizure"},{"issue":"01","key":"ref61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.25130\/tjphs.2013.9.1.1.1.18","article-title":"The effect of treatment with antiepileptic drugs (carbamazepine, valproic acid, topiramate, and their combination) on lipid profile, C-reactive protein, and renal function in Iraqi epileptic patients","volume":"9","author":"M Y Radeef","year":"2013","journal-title":"Tikrit J Pharm Sci"},{"issue":"02","key":"ref62","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1460-9592.2005.01415.x","article-title":"Topiramate and metabolic acidosis: a case series and review of the literature","volume":"15","author":"K Groeper","year":"2005","journal-title":"Paediatr Anaesth"},{"issue":"04","key":"ref63","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00240-010-0347-5","article-title":"Nephrolithiasis in topiramate users","volume":"39","author":"N M Maalouf","year":"2011","journal-title":"Urol Res"},{"issue":"08","key":"ref64","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1185\/030079907X210499","article-title":"Zonisamide and renal calculi in patients with epilepsy: how big an issue?","volume":"23","author":"S Wroe","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"04","key":"ref65","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1053\/j.ajkd.2006.07.003","article-title":"Biochemical and stone-risk profiles with topiramate treatment","volume":"48","author":"B J Welch","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"06","key":"ref66","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/bcp.12283","article-title":"Metabolic disturbances and renal stone promotion on treatment with topiramate: a systematic review","volume":"77","author":"V G Dell'Orto","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"01","key":"ref67","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/bcp.12751","article-title":"Alkali replacement raises urinary citrate excretion in patients with topiramate-induced hypocitraturia","volume":"81","author":"R A Jhagroo","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"07","key":"ref68","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s10072-014-1701-0","article-title":"Anticonvulsant drugs and hematological disease","volume":"35","author":"A Verrotti","year":"2014","journal-title":"Neurol Sci"},{"issue":"08","key":"ref69","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1528-1157.1997.tb01252.x","article-title":"Safety of long-term lamotrigine in epilepsy","volume":"38","author":"F J Mackay","year":"1997","journal-title":"Epilepsia"},{"issue":"02","key":"ref70","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/15563650902752376","article-title":"Carnitine in the treatment of valproic acid-induced toxicity","volume":"47","author":"P E Lheureux","year":"2009","journal-title":"Clin Toxicol (Phila)"},{"issue":"05","key":"ref71","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0404.2008.01009.x","article-title":"Hepatotoxicity associated with antiepileptic drugs","volume":"118","author":"E Bj\u00f6rnsson","year":"2008","journal-title":"Acta Neurol Scand"},{"issue":"06","key":"ref72","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5414\/CP202282","article-title":"A case of lacosamide-induced hepatotoxicity","volume":"53","author":"J S Sunwoo","year":"2015","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.seizure.2021.05.010","article-title":"Cosmetic adverse effects of antiseizure medications; a systematic review","volume":"91","author":"A A Asadi-Pooya","year":"2021","journal-title":"Seizure"},{"issue":"10","key":"ref74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.22159\/ajpcr.2020.v13i10.38761","article-title":"Case report on phenytoin-induced iatrogenic gingival hyperplasia","volume":"13","author":"L N Gunturu","year":"2020","journal-title":"Asian J Pharm Clin Res"}],"container-title":["Seminars in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1958-0802.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T18:30:48Z","timestamp":1701196248000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1958-0802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":73,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2022,12,13]]},"published-print":{"date-parts":[[2022,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1958-0802","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0271-8235","1098-9021"],"issn-type":[{"value":"0271-8235","type":"print"},{"value":"1098-9021","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,10]]},"published":{"date-parts":[[2022,10]]}}}